Section snippets
Methods
iPSCs from a control individual were directed to HIOs and then dissociated to generate purified populations of epithelial only-HIOs (eHIOs). eHIOs were passaged weekly in proliferation medium (EGF, Noggin and CHIR99021) and the γ-secretase inhibitor, DAPT, was added to direct towards a Paneth cell fate. Flow cytometry, qPCR and immunocytochemistry were used to estimate Paneth cell number, gene expression and presence of various AMPs respectively. To confirm the functionality of this cell type,Results
iPSC-derived eHIOs could be maintained for at least 4 months in proliferation medium. Flow cytometry analysis of the Paneth marker lysozyme revealed that the population of Paneth cells in eHIOs significantly increased from ∼1% in proliferation media to ∼30% upon treatment with DAPT. qPCR analysis demonstrated that DAPT treatment significantly increased the expression of the Paneth cell associated genes DEFA5, DEFA6, ITLN2, REG3A and PLA2G2A. Immunoctyochemistry revealed that DAPT treated eHIOsConclusion
We have successfully developed a methodology to enrich Paneth cells in iPSC-derived HIOs. Given that iPSCs can be generated from donor cells stored in well characterized biorepositories or from a small blood draw from any CD patient, this modeling system now opens a new avenue of research by allowing an examination of how environmental factors (microbes/cytokines) and/or genetic variations influence human Paneth cell function in a personalized manner.. qPCR analysis of Paneth cell related genes
扫码关注我们
求助内容:
应助结果提醒方式:
